top of page
Mirabegron

米拉貝隆
Mechanism of action:
Mirabegron 屬於 β₃-腎上腺素受體促效劑(β₃-adrenergic agonist)。當 mirabegron 活化膀胱逼尿肌上的 β₃ 受體,會啟動 Gs 蛋白-cAMP 訊號途徑,促進逼尿肌放鬆,減少逼尿肌過度收縮(detrusor overactivity)。
Reference(s):
1. Takasu T et al. (2007). Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther.
2. Kashyap M et al. (2013). The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option. Expert Opin Drug Metab Toxicol.
bottom of page
